| Report Title | Price | Action |
|---|---|---|
| Global Non-Insulin Hypoglycemic Drug Market Growth 2022-2028
The global market for Non-Insulin Hypoglycemic Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR ...
Published: Nov-2022 | No. of Pages: 114
|
$ 3660 | |
| Global Huoxiang Zhengqi for COVID-19 Market Growth 2022-2028
The global market for Huoxiang Zhengqi for COVID-19 is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR ...
Published: Nov-2022 | No. of Pages: 101
|
$ 3660 | |
| Global Obstetrics and Gynecology Drugs Market Growth (Status and Outlook) 2022-2028
The global market for Obstetrics and Gynecology Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAG...
Published: Nov-2022 | No. of Pages: 110
|
$ 3660 | |
| Global Vitamin Spray Market Growth 2022-2028
The global market for Vitamin Spray is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022...
Published: Nov-2022 | No. of Pages: 119
|
$ 3660 | |
| Global Intravenous Anticoagulants Market Growth 2022-2028
Anticoagulants are medicines that prevent blood clots from forming and stop existing clots from growing bigger._x000D_ The global market for Intraven...
Published: Nov-2022 | No. of Pages: 105
|
$ 3660 | |
| Global PPARδ Agonist Market Growth 2022-2028
Activation of PPARδ enhances fatty acid metabolism._x000D_ The global market for PPARδ Agonist is estimated to increase from US$ million in 2021 to ...
Published: Nov-2022 | No. of Pages: 99
|
$ 3660 | |
| Global PPARα Agonist Market Growth 2022-2028
Activation of PPAR-α reduces triglyceride levels and is involved in the regulation of energy homeostasis._x000D_ The global market for PPARα Agonist...
Published: Nov-2022 | No. of Pages: 127
|
$ 3660 | |
| Global Burosumab Market Growth 2022-2028
Burosumab , a fully human IgG1 monoclonal antibody directed at fibroblast growth factor 23 (FGF23), is indicated for the treatment of X-linked hypopho...
Published: Nov-2022 | No. of Pages: 73
|
$ 3660 | |
| Global Azilsartan Medoxomil Potassium Market Growth 2022-2028
It is a prodrug that can be rapidly converted into the active ingredient Azilsartan after oral absorption, which can selectively block the binding of ...
Published: Nov-2022 | No. of Pages: 79
|
$ 3660 | |
| Global Iron Isomaltoside Market Growth 2022-2028
This is an intravenous iron product that is not only effective in treating iron deficiency, but also preventing anemia and increasing Hb levels after ...
Published: Nov-2022 | No. of Pages: 96
|
$ 3660 | |
| Global Eftrenonacog Alfa Market Growth 2022-2028
Eftrenonacog alfa is a long-acting recombinant fusion protein used in the treatment of hemophilia B. It is comprised of a single molecule of human fac...
Published: Nov-2022 | No. of Pages: 93
|
$ 3660 | |
| Global Satralizumab Market Growth 2022-2028
Satralizumab is a recombinant humanized monoclonal antibody targeted against human interleukin-6 (IL-6) receptors, similar to tocilizumab, which is p...
Published: Nov-2022 | No. of Pages: 74
|
$ 3660 | |
| Global Hyperuricemia Drugs Market Growth 2022-2028
Hyperuricemia is the type of condition wherein an excessive level of uric acid is produced in the blood. The level of uric acid in the blood is the ba...
Published: Nov-2022 | No. of Pages: 104
|
$ 3660 | |
| Global Chronic Bacterial Prostatitis Drugs Market Growth 2022-2028
Chronic bacterial prostatitis (CBP) is a common disease in the urinary system, which is common in young and middle-aged people. Its etiology is comple...
Published: Nov-2022 | No. of Pages: 112
|
$ 3660 | |
| Global Antivenom Drugs Market Growth 2022-2028
Antivenom drugs are used to treat venomous bites and stings, usually preferable in high-toxicity cases. Antivenin, venom antiserum, and antivenom immu...
Published: Nov-2022 | No. of Pages: 118
|
$ 3660 | |
| Global Condyloma Acuminatum Drugs Market Growth 2022-2028
The global market for Condyloma Acuminatum Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of ...
Published: Nov-2022 | No. of Pages: 113
|
$ 3660 | |
| Global Mechanistic Target Of Rapamycin Kinase (MTOR) Antibody Market Growth 2022-2028
Mechanistic Target Of Rapamycin Kinase (MTOR) Antibody is an unconjugated antibody to MTOR._x000D_ The global market for Mechanistic Target Of Rapamyc...
Published: Nov-2022 | No. of Pages: 106
|
$ 3660 | |
| Global Lymphocyte Activating 3 (LAG3) Antibody Market Growth 2022-2028
Lymphocyte Activating 3 (LAG3) Antibody is an unconjugated antibody to LAG3._x000D_ The global market for Lymphocyte Activating 3 (LAG3) Antibody is e...
Published: Nov-2022 | No. of Pages: 108
|
$ 3660 | |
| Global Mitogen-Activated Protein Kinase Kinase 1 (MEK1) Antibody Market Growth 2022-2028
Mitogen-Activated Protein Kinase Kinase 1 (MEK1) Antibody is an unconjugated antibody to MEK1._x000D_ The global market for Mitogen-Activated Protein ...
Published: Nov-2022 | No. of Pages: 109
|
$ 3660 | |
| Global Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Antibody Market Growth 2022-2028
Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Antibody is an unconjugated antibody to NTRK2._x000D_ The global market for Neurotrophic Receptor Tyro...
Published: Nov-2022 | No. of Pages: 108
|
$ 3660 |